DCF — BILLINGS CLINIC BROADWATER
Enterprise Value: $-15.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-15.0M
Enterprise Value
$-4.8M
PV of Cash Flows
$-10.2M
PV of Terminal Value
$-16.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $9.8M | $-0.9M | -9.0% | $-1.3M | $-1.2M |
| Year 2 | $10.1M | $-0.9M | -8.0% | $-1.3M | $-1.1M |
| Year 3 | $10.4M | $-0.8M | -7.0% | $-1.2M | $-0.9M |
| Year 4 | $10.7M | $-0.7M | -7.0% | $-1.2M | $-0.8M |
| Year 5 | $11.0M | $-0.7M | -7.0% | $-1.2M | $-0.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-15.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$9.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09917049070336986
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5